Lyell Immunopharma Inc
Closed
19.23 0.37
Overview
Share price change
24h
Min
19
Max
19.32
Income | 117M -24M |
|---|---|
Sales | -4K 2K |
EPS | -1.1 |
Profit margin | -1,207,650 |
Employees | 300 |
EBITDA | 16M -44M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +91.17% upside |
Next Earnings | 10 Aug 2026 |
|---|
Market Cap | -35M 448M |
|---|---|
Previous open | 18.86 |
Previous close | 19.23 |
Technical Score
By Trading Central
Confidence
Strong Bearish Evidence
Lyell Immunopharma Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Lyell Immunopharma Inc Forecast
Price Target
By TipRanks
91.17% upside
12 Months Forecast
Average 36.8 USD 91.17%
High 49 USD
Low 12 USD
Based on 5 Wall Street analysts offering 12 month price targets forLyell Immunopharma Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$